Displaying 1 - 12 of 47
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View